local_hospital

Centre Hospitalier Annecy Genevois

Address
1 Avenue de l'Hôpital BP 90074, 74374 Epagny Metz Tessy, France

Centre Hospitalier Annecy Genevois - Infectious Neurology Research

Centre Hospitalier Annecy Genevois is advancing the treatment of serious central nervous system infections through innovative clinical research. The center specializes in optimizing antibiotic therapy for complex neurological infections, with a particular focus on improving patient outcomes while reducing treatment burden.

  • Bacterial brain abscess management and treatment optimization
  • Comparative effectiveness of oral versus intravenous antibiotic regimens
  • Central nervous system infectious diseases

The facility is conducting groundbreaking research in bacterial brain abscess treatment, evaluating whether partial oral antibiotic therapy can provide comparable efficacy to traditional intravenous approaches. This work has important implications for patient quality of life, healthcare resource utilization, and the development of more flexible treatment protocols for severe neurological infections.

Site Overview

assignment
2
connected trials
corporate_fare
2
sponsors
science
17
IMPs

Activity Indicator

Last 6 months

0
Trials started
0
Trials started 6–12 months ago
2
Total trials linked
Moderately Active
trending_flatStable0%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status

Top 3 therapeutic areas and 15 of 17 IMPs, ranked by number of trials.

lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
1
Sponsors (total)
2
Active sponsors
1

Sponsor Network

Top 1 by active trials.

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

No repeated partnerships found.

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 978 other sites in France

description
Trial volume
2
Outperforms 44% of sites
public
Therapeutic diversity
3areas
Outperforms 59% of sites
groups
Sponsor diversity
2sponsors
Outperforms 45% of sites

Therapeutic Area Benchmark — France

Select a therapeutic area to compare against other sites in France.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: France

Market Share

Country: France

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Centre Hospitalier Annecy Genevois

lock Showing 1 of 2 trials — the rest is available on a paid plan.

IMP list

lock Showing 1 of 17 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Abemaciclib1Unknown2024-03-252024-03-25

Request feasibility information

Ask this centre about capacity, equipment and patient population.

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.